In this study, we have taken a complementary strategy to profile genome-wide DNA methylation in the human hippocampus, a brain region particularly vulnerable to AD [17–19] and the core of pathological protein tau deposits [20]. The gene discussed is MAPT; the disease is Alzheimer disease.